Free Trial

CVS Health (CVS) Earnings Date, Estimates & Call Transcripts

CVS Health logo
$56.83 +1.06 (+1.90%)
(As of 11/20/2024 ET)

CVS Health Latest Earnings Summary

Upcoming Q4
Earnings Date
Feb. 5Estimated
Actual EPS
(Nov. 6)
$1.09 Beat By $0.02
Consensus EPS
(Nov. 6)
$1.08

CVS Health released Q3 2024 earnings on November 6, 2024, reporting an EPS of $1.09, which beat analysts' consensus estimates of $1.08 by $0.02. Quarterly revenue rose 6.3% year-over-year to $95.43 billion, above analyst estimates of $92.72 billion. With a trailing EPS of $3.94 and a P/E Ratio of 14.42, CVS Health's earnings are expected to grow 21.17% next year, from $5.48 to $6.64 per share.

CVS Upcoming Earnings

CVS Health's next earnings date is estimated for Wednesday, February 5, 2025, based off prior year's reporting schedules.

Get CVS Health Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CVS Health and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CVS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CVS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

CVS Health Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20243$1.76$2.24$2.02 
Q2 20243$1.65$2.33$2.05 
Q3 20243$1.70$2.22$1.991.050 - 1.100
Q4 20243$1.24$2.36$1.94 
FY 202412$6.35$9.15$8.00 
Q1 20252$1.33$2.26$1.80 
Q2 20252$1.71$2.20$1.96 
Q3 20251$1.81$1.81$1.81 
Q4 20251$1.43$1.43$1.43 
FY 20256$6.28$7.70 $6.99

CVS Health Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/5/2025
(Estimated)
------- 
11/6/2024Q3 2024$1.0750$1.09+$0.0150$2.11$92.72B$95.43B          
8/7/2024Q2 2024$1.73$1.83+$0.10$2.25$91.41B$91.23B          
5/1/2024Q1 2024$1.69$1.31 -$0.38$1.74$89.33B$88.44B          
2/7/2024Q4 2023$2.01$2.12+$0.11$2.66$90.58B$93.81B          
11/1/2023Q3 2023$2.13$2.21+$0.08$2.67$88.29B$89.76B          
8/2/2023Q2 2023$2.12$2.21+$0.09$2.94$86.41B$88.92B          
5/3/2023Q1 2023$2.07$2.20+$0.13$2.75$80.67B$85.28B          
2/8/2023Q4 2022$1.92$1.99+$0.07$2.23$76.37B$83.85B          

CVS Health Earnings - Frequently Asked Questions

CVS Health has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 5th, 2025 based off last year's report dates. Learn more on CVS's earnings history.

CVS Health updated its third quarter earnings guidance on Friday, October, 18th. The company provided earnings per share guidance of $1.05-1.10 for the period, compared to the consensus EPS estimate of $1.69.

In the previous quarter, CVS Health (NYSE:CVS) reported $1.09 earnings per share (EPS) to beat the analysts' consensus estimate of $1.08 by $0.02. Learn more on analysts' earnings estimate vs. CVS's actual earnings.

The conference call for CVS Health's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for CVS Health's latest earnings report can be read online.
Read Transcript

CVS Health's earnings report can be found in their filing with the SEC.
View SEC filing

CVS Health (NYSE:CVS) has a recorded annual revenue of $368.91 billion.

CVS Health (NYSE:CVS) has a recorded net income of $8.34 billion. CVS has generated $3.94 earnings per share over the last four quarters.

CVS Health (NYSE:CVS) has a trailing price-to-earnings ratio of 14.42 and a forward price-to-earnings ratio of 10.37. The price/earnings-to-growth ratio is 0.92.

CVS Health's earnings are expected to grow from $5.48 per share to $6.64 per share in the next year, which is a 21.17% increase.

`

More Earnings Resources from MarketBeat



This page (NYSE:CVS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners